Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 3 | 10 |
| List of Tables | 5 | 4 |
| List of Figures | 9 | 4 |
| Clinical Trials in Orphan Diseases: Introduction | 13 | 1 |
| Disease Overview | 13 | 1 |
| The US | 13 | 1 |
| Europe | 13 | 1 |
| Japan | 13 | 1 |
| GBI Research Report Guidance | 13 | 1 |
| Clinical Trials and Patient Recruitment for Orphan Diseases in Central Nervous System(CNS) | 14 | 32 |
| Huntington s disease | 14 | 1 |
| Introduction | 14 | 1 |
| Number of Clinical Trials for Huntington s disease | 15 | 1 |
| Number of Clinical Trials by Phase | 15 | 1 |
| Number of Clinical Trials by Major Sponsors | 16 | 1 |
| Number of Clinical Trials by Geography | 17 | 1 |
| Number of Clinical Trials by Year | 18 | 1 |
| Prevalence Population for Huntington s disease (2010-2017) | 19 | 1 |
| The US | 19 | 1 |
| Europe | 20 | 1 |
| Japan | 21 | 1 |
| Patient Recruitment for Huntington s Disease | 22 | 1 |
| Number of Patients Recruited by Phase of Clinical Trials | 22 | 1 |
| Number of Patients Recruited by Major Sponsors | 23 | 1 |
| Number of Patients Recruited by Geography | 24 | 1 |
| Number of Patients Recruited per Year | 25 | 1 |
| Average Number of Patients Recruited Per Trial | 26 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 26 | 1 |
| Average Number of Patients Recruited per Trial per Year | 27 | 1 |
| Amyotrophic Lateral Sclerosis (ALS) | 28 | 1 |
| Introduction | 28 | 1 |
| Number of Clinical Trials for Amyotrophic Lateral Sclerosis | 29 | 1 |
| Number of Clinical Trials by Phase | 29 | 1 |
| Number of Clinical Trials by Sponsor | 30 | 1 |
| Number of Clinical Trials by Geography | 31 | 1 |
| Number of Clinical Trials by Year | 32 | 1 |
| Prevalence Population for ALS (2010-2017) | 33 | 1 |
| The US | 33 | 1 |
| Europe | 34 | 1 |
| Japan | 35 | 1 |
| Patient Recruitment for Amyotrophic Lateral Sclerosis | 36 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 36 | 1 |
| Number of Patients Recruited By Sponsor | 37 | 1 |
| Number of Patients Recruited By Geography | 38 | 1 |
| Number of Patients Recruited per Year | 39 | 1 |
| Average Number of Patients Recruited Per Trial | 40 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 40 | 1 |
| Average Number of Patients Recruited per Trial per Year | 41 | 1 |
| Comparison of Clinical Trials and Patient Recruitment of Orphan Diseases with Other CNS Diseases | 42 | 1 |
| Number of Clinical Trials | 42 | 1 |
| Number of Patients Recruited | 43 | 1 |
| Average Number of Patients Recruited per Phase | 44 | 1 |
| Average Number of Patients Recruited per Year | 45 | 1 |
| Clinical Trials and Patient Recruitment for Orphan Diseases in Oncology | 46 | 74 |
| Ovarian Cancer | 46 | 1 |
| Introduction | 46 | 1 |
| Number of Clinical Trials for Ovarian Cancer | 47 | 1 |
| Number of Clinical Trials by Phase | 47 | 1 |
| Number of Clinical Trials by Major Sponsor | 48 | 1 |
| Number of Clinical Trials by Geography | 49 | 1 |
| Number of Clinical Trials by Year | 50 | 1 |
| Prevalence Population for Ovarian Cancer (2010-2017) | 51 | 1 |
| The US | 51 | 1 |
| Europe | 52 | 1 |
| Japan | 53 | 1 |
| Patient Recruitment for Ovarian Cancer | 54 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 54 | 1 |
| Number of Patients Recruited by Major Sponsors | 55 | 1 |
| Number of Patients Recruited by Geography | 56 | 1 |
| Number of Patients Recruited per Year | 57 | 1 |
| Average Number of Patients Recruited Per Trial | 58 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 58 | 1 |
| Average Number of Patients Recruited per Trial per Year | 59 | 1 |
| Pancreatic Cancer | 60 | 1 |
| Introduction | 60 | 1 |
| Number of Clinical Trials for Pancreatic Cancer | 61 | 1 |
| Number of Clinical Trials by Phase | 61 | 1 |
| Number of Clinical Trials by Major Sponsors | 62 | 1 |
| Number of Clinical Trials by Geography | 63 | 1 |
| Number of Clinical Trials by Year | 64 | 1 |
| Prevalence Population for Pancreatic Cancer (2010-2017) | 65 | 1 |
| The US | 65 | 1 |
| Europe | 66 | 1 |
| Japan | 67 | 1 |
| Patient Recruitment for Pancreatic cancer | 68 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 68 | 1 |
| Number of Patients Recruited by Major Sponsors | 69 | 1 |
| Number of Patients Recruited By Geography | 70 | 1 |
| Number of Patients Recruited Per Year | 71 | 1 |
| Average Number of Patients Recruited Per Trial | 72 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 72 | 1 |
| Average Number of Patients Recruited per Trial per Year | 73 | 1 |
| Multiple Myeloma | 74 | 1 |
| Introduction | 74 | 1 |
| Number of Clinical Trials for Multiple Myeloma | 75 | 1 |
| Number of Clinical Trials by Phase | 75 | 1 |
| Number of Clinical Trials by Sponsor | 76 | 1 |
| Number of Clinical Trials by Geography | 77 | 1 |
| Number of Clinical Trials by Year | 78 | 1 |
| Prevalence Population for Multiple Myeloma (2010-2017) | 79 | 1 |
| The US | 79 | 1 |
| Europe | 80 | 1 |
| Japan | 81 | 1 |
| Patient Recruitment for Multiple Myeloma | 82 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 82 | 1 |
| Number of Patients Recruited By Major Sponsors | 83 | 1 |
| Number of Patients Recruited By Geography | 84 | 1 |
| Number of Patients Recruited Per Year | 85 | 1 |
| Average Number of Patients Recruited Per Trial | 86 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 86 | 1 |
| Average Number of Patients Recruited per Trial per Year | 87 | 1 |
| Hodgkin s Lymphoma | 88 | 1 |
| Introduction | 88 | 1 |
| Number of Clinical Trials for Hodgkin s Lymphoma | 88 | 1 |
| Number of Clinical Trials by Phase | 88 | 2 |
| Number of Clinical Trials by Sponsor | 90 | 1 |
| Number of Clinical Trials by Geography | 91 | 1 |
| Number of Clinical Trials by Year | 92 | 1 |
| Prevalence Population for Hodgkin s Lymphoma (2010-2017) | 93 | 1 |
| The US | 93 | 1 |
| Europe | 94 | 1 |
| Japan | 95 | 1 |
| Patient Recruitment for Hodgkin s Lymphoma | 96 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 96 | 1 |
| Number of Patients Recruited By Major Sponsors | 97 | 1 |
| Number of Patients Recruited By Geography | 98 | 1 |
| Number of Patients Recruited Per Year | 99 | 1 |
| Average Number of Patients Recruited Per Trial | 100 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 100 | 1 |
| Average Number of Patients Recruited per Trial per Year | 101 | 1 |
| Acute Myelocytic Leukemia (AML) | 102 | 1 |
| Introduction | 102 | 1 |
| Number of Clinical Trials for Acute Myelocytic Leukemia | 103 | 1 |
| Number of Clinical Trials by Phase | 103 | 1 |
| Number of Clinical Trials by Sponsor | 104 | 1 |
| Number of Clinical Trials by Geography | 105 | 1 |
| Number of Clinical Trials by Year | 106 | 1 |
| Prevalence Population for Acute Myelocytic Leukemia (2010-2017) | 107 | 1 |
| The US | 107 | 1 |
| Europe | 108 | 1 |
| Japan | 109 | 1 |
| Patient Recruitment for Multiple Myeloma | 110 | 1 |
| Number of Patients Recruited By Phase of Clinical Trial | 110 | 1 |
| Number of Patients Recruited By Major Sponsors | 111 | 1 |
| Number of Patients Recruited By Geography | 112 | 1 |
| Number of Patients Recruited Per Year | 113 | 1 |
| Average Number of Patients Recruited Per Trial | 114 | 1 |
| Average Number of Patients Recruited per Trial by Stage of Development | 114 | 1 |
| Average Number of Patients Recruited per Trial per Year | 115 | 1 |
| Comparison of Clinical Trials and Patient Recruitment of Orphan Diseases with Other Oncology Diseases | 116 | 1 |
| Number of Clinical Trials | 116 | 1 |
| Number of Patients Recruited | 117 | 1 |
| Average Number of Patients Recruited per Phase | 118 | 1 |
| Average Number of Patients Recruited per Year | 119 | 1 |
| Clinical Trial Recruitment in Orphan Diseases-Appendix | 120 | 4 |
| Market Definitions | 120 | 1 |
| Abbreviations | 120 | 1 |
| Research Methodology | 120 | 3 |
| Coverage | 120 | 1 |
| Secondary Research | 121 | 1 |
| Primary Research | 121 | 1 |
| Expert Panel Validation | 121 | 1 |
| Section-wise methodology | 121 | 1 |
| Clinical Trials Overview | 122 | 1 |
| Number of Clinical Trials | 122 | 1 |
| Patient Recruitment Status | 122 | 1 |
| Prevalence of Disease in the US, Europe and Japan (2010-2017) | 122 | 1 |
| Contact Us | 123 | 1 |
| Disclaimer | 123 | 1 |
| Sources | 123 | 1 |